Target Protein Degradation Market is projected to be over USD 3.6 billion by 2030 | Roots Analysis

The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare. The first targeted protein degrader, called proteolysis targeting chimera (PROTAC), was developed about a decade ago.

Presently, a variety of other such chemical entities and molecular glues are under investigation. In fact, certain pipeline candidates are already in the mid to late-phase trials and are anticipated to soon enter the market.

The USD 3.6 billion (by 2030) financial opportunity within the Target Protein Degradation Market has been analyzed across the following segments:

Type of payment of licensing agreements

  • Upfront payments
  • Milestone payments

Type of protein degrader

  • Degronimids
  • PROTACs
  • SARDs / SERDs
  • Specific BET and DUB inhibitors
  • Other protein degraders

Therapeutic area

  • Neurodegenerative disorders
  • Oncological disorders
  • Other therapeutic areas

Route of administration 

  • Oral
  • Intravenous
  • Other routes

Key geographical region

  • North America
  • Europe
  • Asia-Pacific

The Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, SNIPERs, and Specific BET and DUB Inhibitors), 2020-2030 report features the following companies, which we identified to be key players in this domain:

Get detailed Analysis: https://www.rootsanalysis.com/reports/289/request-sample.html

Key Players

  • Arvinas
  • Captor Therapeutics
  • Celgene
  • Genetech
  • Kymera Therapeutics
  • Mission Therapeutics
  • Progenra
  • Radius Health 
  • Sanofi Genzyme
  • Zenopharm

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Current Market Landscape

5. Company Profiles

6. Clinical Trial Analysis

7. KOL Analysis

8. Publication Analysis

9. Funding and Investment Analysis

10. Partnerships and Collaborations

11.  Market Sizing and Opportunity Analysis

12. Executive Insights

13. Concluding Remarks

14. Appendix 1: Tabulated Data

15. Appendix 2: List of Companies and Organizations

Get Customized Report: https://www.rootsanalysis.com/reports/289/request-customization.html

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]



Source : NewsOnFloor

Related Articles

Comments (4)

  • - Russell Holder

    Russell Holder is a research writer and has been associated with different writing agencies in the time frame of four years We've seen a lot of his blogs, which is why we get so much inspiration from his writing. Nowadays, he is working on a website that is assignmentmaster.co.uk review. Russell is a pro at researching related content and paraphrasing it to make his pieces unique and plagiarism-free. He also provides the cheapest writing services as a freelancer.

  • - zena bartell

    This game ( slope unblocked ) is a mood changer. Am I right!

  • - Thomas

    Protein is as necessary as a good writing company for the students who are stuck in their academic process.

  • - samuelMiller

    Such incredible advancements are taking the pharma industry to a higher level, I recently write my dissertation online on the benefits and future of the target protein degradation market and that research give me some amazing results.a

Leave a Comment